Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 11/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 10/20 | 0.40 |
| ▸ | P2RY4 | P51582 | 9/20 | 0.40 |
| ▸ | TYMP | P19971 | 6/20 | 0.39 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.36 |
| ▸ | NT5E | P21589 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9230969 | 0.94 | P2RY6 (0.41) | P2RY6P2RY2P2RY4TYMPP2RY14 | |
| SCHEMBL9231628 | 0.86 | TYMP (0.43) | TYMPNT5E | |
| SCHEMBL9232489 | 0.85 | P2RY2 (0.44) | P2RY6P2RY2P2RY4 | |
| SCHEMBL9232487 | 0.85 | P2RY2 (0.44) | P2RY6P2RY2P2RY4 | |
| SCHEMBL7756536 | 0.84 | TYMP (0.46) | TYMP | |
| SCHEMBL7753939 | 0.84 | P2RY2 (0.43) | P2RY6P2RY2P2RY4TYMPP2RY14 | |
| SCHEMBL10499351 | 0.83 | TYMP (0.39) | P2RY6P2RY2P2RY4TYMPNT5E | |
| SCHEMBL8712130 | 0.79 | POLB (0.42) | P2RY6P2RY2P2RY4TYMP | |
| SCHEMBL9231847 | 0.78 | P2RY2 (0.45) | P2RY6P2RY2P2RY4 | |
| SCHEMBL9231845 | 0.78 | P2RY2 (0.45) | P2RY6P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0661291-B1 | Solid phase synthesis of oligoribonucleotide | AVENTIS PHARMA GMBH (DE) | 2001-03-07 | — | — | EP | disclosed |
| EP-0661291-A1 | Solid phase synthesis of oligoribonucleotide | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-07-05 | — | — | EP | disclosed |